Pharmacy Podcast Network

Join panelists Robert Kushner, MD, Jamy Ard, MD, and Jaime Almandoz, MD, to learn about BMI as a measure of excess adiposity, exploring both its strengths and limitations. Speakers:  -          Bob Kushner, MD  -          Jamy Ard, MD, FTOS -          Jaime Almandoz, MD, MBA, MRCPI, FTOS   This podcast is sponsored by Novo Nordisk and is intended for clinicians. Novo Nordisk is a registered trademark of Novo Nordisk A/S. All other trademarks, registered or unregistered, are the property of their respective owners. © 2025 Novo Nordisk All rights reserved. US24OB00077 June 2025

Welcome (back) to the Opioidology podcast series! Next up to bat, ‘Opioid Selection”. What’s YOUR “Go To Opioid”??? No really, pick a given patient scenario, as respectively there’s many, and what is your “Go To Opioid” when a prescription opioid is warranted??? Pain Guy posed this question on LinkedIn over a year ago, and society failed (as in succumbed to the Opioidphobia culture). So join us in this episode to take a methodical journey distinguishing prescription opioids to once and for (almost) all, be able to have our ducks in a row for opioid selection. Listen in to this Pain Pod episode for an unbiased, in your face, here’s how it is approach to explaining opioid selection (beyond the “To Opioid or Not to Opioid” debate). Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

In part two of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025. Our guests are: Kris Rhea with Pharmacy Market Place Outcomes Director of Product Management, Matt Kiethanom  Bonnie Bond with Sykes and Company Accounting Vice President of Product Management at Outcomes, Dr. Heidi Polek and Kunal Vyas, CEO of RxMile CEO of the Alliance for Pharmacy Compounding, Scott Brunner  Dr. Mark Amoo with Outcomes   This episode is sponsored by Outcomes.

Multi-store owners: Are running payroll through all of your locations? This episode is a must listen... In this episode of Master the Margin, Scotty Sykes, CPA, CFP® and Kathy Blanchard, Senior Pharmacy Accountant, dive into the nuances of common paymaster status and why it’s often misunderstood in multi-store pharmacy operations.  They break down:  - What a common paymaster is—and how it (theoretically) benefits employers  - Why most multi-store pharmacy owners don’t qualify, despite good intentions  - The payroll risks of misclassifying employees across entities  - The role of controlled group rules in IRS compliance  - How common ownership impacts payroll, 401(k)s, benefits, and more  Check out the full episode with bonus insights: https://masterthemargin.substack.com/ Schedule an Rx Assessment: https://www.sykes-cpa.com/rx-assessment-service/  More resources about this topic: Podcast - One Big, Beautiful Bill: What the New Tax Proposal Means for Pharmacies: https://www.youtube.com/watch?v=99jnN08jGUo Podcast - The Multi Store Owners Guide to Selling Your Pharmacy: https://www.youtube.com/watch?v=smmNR_SFOwg

Shaun Jensen, CEO of JB Consulting, shares insights on how AI is revolutionizing specialty pharmacy, particularly in clinical decision support and patient engagement. Ketan Mehta, CEO of PrimeRx, discusses the upcoming PrimeRx User Conference 2025, focusing on technology's role in empowering independent pharmacies. Together, they explore the future of pharmacy operations, highlighting AI's efficiency gains and the importance of community engagement in adapting to industry challenges.

In part one of this three part series we bring you exclusive interviews from the Outcomes booth, recorded on the show floor at ThoughtSpot 2025. Our guests are: One of 2024's most Influential People in Pharmacy Dr. Jay Phipps, the Pharmacy Gladiator VP of Pharmacy Insights at Outcomes, Jonathan Grice Vice President of Retail Pharmacy at Outcomes, Mark Nelson Vice President of Product Management at Outcomes, Dr. Heidi Polek   This episode is sponsored by Outcomes.

In this episode of FrameworkFocus, we explore how the long-term care (LTC) market has evolved from the pre-pandemic boom through COVID-19’s sharp disruption to today’s near-recovery. Jason Yablinsky, CFO at SoftWriters, unpacks how shifting interest rates, housing liquidity, and the coming wave of Baby Boomer demand are reshaping the industry’s trajectory. Tune in to learn why today’s financial constraints may soon become tomorrow’s catalysts for growth.

I know I say this every time, but this episode is truly special as I interview a fellow herbalist about her story of creating a skincare line that’s built on compassion for people and the planet.  Aviva Tilson is the founder of Apis Apotheca, which she began 8 years ago when combining her experience with organic farming, herbalism, and desire to resolve lifelong skin issues. She specializes in sensitive, eczema and acne prone skin and continues to delve into the complexity of managing skin issues in the context of autoimmunity.  Aviva’s products are poems that arose from the inspiration of her garden, and the desire to show an example of a heart-centered business that is full circle and has a basis in regenerative agriculture. Her line has helped thousands of people around the globe heal their skin and feel closer to nature in the process. Tune in to hear how you can support radiant beauty within and on your skin with botanicals from the garden. Connect with Aviva via: Email: contact@apisapotheca.com  Website: Apis Apotheca FB: Apis Apotheca IG: @apis.apotheca.farm Linked In: Apis Apotheca HERMES free one time shipping code

This week on TWIRx, we cover the latest headlines shaping pharmacy care, followed by three powerful interviews spotlighting innovation, advocacy, and access. TWIRx News: 13WHAM ABC News: Health Center Turns Away Patients as Medicaid Approval Stalls Pharmacy Services – A troubling look at how bureaucratic delays are cutting off critical access to care for vulnerable populations. Pharmacy Times: Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling – Why pharmacists need more education to better guide patients on the risks and benefits of this controversial substance. Pharmacy Times: Navigating Biosimilars and 505(b)(2) Drugs in Oncology – Operational, clinical, and policy strategies to help pharmacists drive adoption and improve cancer care access. Featured Interviews: Ritesh Shah – Founder, Ritesh Shah Charitable Pharmacy Author of Pills to Purpose: From the Pharmacy to the Frontlines: Healing Beyond the Counter, Ritesh shares his journey from personal loss to creating New Jersey’s first charitable pharmacy—ensuring life-saving medications reach those most in need with dignity and compassion. Bonnie Bonds – Sykes & Company Live from the 2025 ThoughtSpot Conference, Bonnie brings insights on the financial strategies independent pharmacies need to grow, adapt, and thrive. Srulik Dvorsky – CEO & Co-founder, TailorMed How technology is being used to eliminate financial barriers to care and connect patients with the resources they need to afford treatment. Sponsored by: Sykes & Company – Helping pharmacies succeed with expert accounting, tax, and advisory services. 🎧 Listen now for the news, perspectives, and inspiration driving the pharmacy profession forward.   "Pills to Purpose" is a book and the name of Ritesh Shah's charitable pharmacy. The book, "Pills to Purpose: From the Pharmacy to the Frontlines: Healing Beyond the Counter", is a memoir about Ritesh Shah's journey from personal loss to founding New Jersey's first charitable pharmacy, Ritesh Shah Charitable Pharmacy. The pharmacy's mission is to provide access to life-saving medications for those in need, ensuring they are treated with dignity and compassion. The book highlights the power of service and how individual actions can create a movement for positive change, according to a post on Amazon.    

In the second installment of our 3-part KeySource Series on the Pharmacy Podcast Network, Andrew Crawford, VP of Sales & Marketing at KeySource, joins Todd Eury to explore one of the most urgent priorities for regional and national chain pharmacies — supplier alignment as a driver of strategic growth. With NACDS TSE right around the corner, this conversation takes a hard look at the pressures chains face today — from unpredictable PBM reimbursements and restrictive PVA contracts to the operational ripple effects of even a single NDC disruption. At chain scale, where central fill and automation keep thousands of prescriptions moving daily, stability, flexibility, and strategic control are non-negotiable. In this episode, we cover: The State of Chains: How PBM volatility, slim PVA margins, and supply continuity challenges are reshaping priorities. The Shift Toward Supplier Alignment: Why leading chains are moving beyond rigid structures to build strategic, responsive partnerships. How KeySource Supports Chain Growth: From NDC continuity to opportunistic buys, primary award support, and autonomy beyond PVA constraints. Strategic Support Beyond the Product: The downstream impact of supply instability — and how proactive supplier partnerships mitigate risk. Looking Ahead to NACDS TSE: How to turn supplier relationships into a competitive edge. Whether you manage a regional chain or lead procurement for a national brand, this episode unpacks the supplier strategies that can protect your operations, enable growth, and strengthen your competitive position in a volatile market. 📍 Attending NACDS TSE? Visit KeySource at Booth #3523 to discuss supply chain alignment, growth strategies, and new value opportunities for your pharmacy network.